2018 Transactional Trends: Key Issues for Cross-Border Deals; Focus on Emerging and Mid-Size Companies

By Greg Benning

Back Bay Life Science Advisors recently co-hosted DKBIO 2018: Danish Science & The City at Harvard Medical School focused on cross-border investment and transactions in the life sciences sector.Back Bay’s M&A team presented information on the IPO, M&A and Venture markets, with a specific focus on mid-size companies, that finds clear shifts in money flow, M&A, IPOs, and VC investing volumes, as well as top-10 rankings.Click here to download the PDF, Transactional Trends: Key Issues for Cross-Border Deals; Focus on Emerging and Mid-Size Companies.We are pleased to share these with the firm’s clients and friends, and very much welcome opportunities to discuss specific insights with you in more detail.Best regards,Greg BenningManaging Director, M&ABack Bay Life Science Advisors